Home » Topics » Regulatory

Regulatory
RSS

Genentech submits NDA to FDA for Nutropin Depot

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Fosamax receives FDA approval for glucocorticoid-induced osteoporosis

June 29, 1999

Ethyol approved by FDA for radiation-induced dry mouth

June 28, 1999

HIV protease inhibitor Agenerase now available in oral solution

June 28, 1999

Olanzapine effective in management of bipolar disorder

June 28, 1999

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

June 25, 1999

Daclizumab may have applications in uveitis therapy

June 25, 1999

FDA clears Cutivate cream for treatment of atopic dermatitis in children

June 25, 1999

Copley launches first controlled drug

June 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.